Novartis breaks ground on new RLT manufacturing site in Denton, Texas
Novartis' first Texas-based manufacturing facility expands US RLT production closer to patients across the southern US, becoming the fifth RLT site nationwide.
Novartis finalizes US expansion plan with seventh new facility
Novartis has added a new facility in Morrisville, North Carolina, building upon end-to-end US production capability.
Discover our medicines
See how our innovative medicines are addressing society's greatest health challenges.
Commitment to patients
From research and development to expanding access, uncover our commitment to improving people's lives.
Inspired by purpose
Learn about our people and culture, and how we're driven by our mission to reimagine medicine.
Latest News
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto™ in metastatic hormone-sensitive prostate cancer
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
